ZYTO retains Aquiline Group as inverstor relations firm

Aquiline Group was retained as ZYTO Corp's (PINKSHEETS: ZYTC) new Investor Relations Firm as of August 10, 2009.

Aquiline Group is to provide ZYTO Corp proven multifaceted techniques to increase its market valuation, liquidity and name recognition. Since appointing Aquiline Group, ZYTO Corp's price per share has increased over 100%.

"We look forward to working with the Aquiline Group as part of our team, and are confident their programs will bring value and measurable results to our company and shareholders," commented Kami Howard, CFO of ZYTO Corp.

"We are very excited about working along side ZYTO as their Public/Investor relations firm. The timing is ripe, their products are in high demand and increasing, and they have a top tier management team who is passionate about the company's long term growth. With those variables in the equation, you can expect a very nice outcome for all of our partners and current shareholders," stated Dio Pouerie, CEO of Aquiline Group.

Aquiline Group is a proactive, performance driven firm that measures its own success in terms of the success of its clients and partners. Its team includes a core network of professionals with direct experience working with publicly traded companies, including: attorneys specialized in securities compliance, regulatory issues and corporate governance; accountants with extensive experiences in public audits; financial consultants able to provide structuring and presentation solutions and marketers using the latest investor communication techniques. In addition, Aquiline Group maintains an in-house promotions floor endowed with top tier account executives who build relationships with brokers from all the major brokerage houses around the nation. Aquiline Group deals directly with the brokerage community and does not solicit individual investors. Please visit Aquilinegroup.com for more information.

Source:

Aquiline Group

Posted in:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.